Novel Oral Nanoemulsion Targets Hepatic Stellate Cells in Liver Fibrosis Treatment
A vitamin A-functionalized self-nanoemulsifying drug delivery system effectively targets hepatic stellate cells in liver fibrosis.
Indication
Clinical and regulatory intelligence for Liver Fibrosis with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.